PubRank

Covid-19 in Immune-Mediated Inflammatory Diseases - Case Series from New York.

PubWeight™: 3.30‹?› | Rank: Top 1%

🔗 View Article (PMID 32348641)

Published in N Engl J Med on April 29, 2020

Authors

Rebecca Haberman1, Jordan Axelrad1, Alan Chen2, Rochelle Castillo1, Di Yan1, Peter Izmirly1, Andrea Neimann1, Samrachana Adhikari2, David Hudesman3, Jose U Scher3

Author Affiliations

1: New York University Langone Health, New York, NY.
2: New York University Grossman School of Medicine, New York, NY.
3: New York University Langone Health, New York, NY jose.scher@nyulangone.org.

Associated clinical trials:

Morbimortality of Covid-19 in Patients With Chronic Inflammatory Rheumatism Treated With Immunosuppressants (CORhum) | NCT04426279

Articles citing this ↘

More on Covid-19 in Immune-Mediated Inflammatory Diseases. Reply. N Engl J Med (2020) 0.75

More on Covid-19 in Immune-Mediated Inflammatory Diseases. N Engl J Med (2020) 0.75

More on Covid-19 in Immune-Mediated Inflammatory Diseases. N Engl J Med (2020) 0.75

More on Covid-19 in Immune-Mediated Inflammatory Diseases. N Engl J Med (2020) 0.75

Articles by these authors ⇆

More on Covid-19 in Immune-Mediated Inflammatory Diseases. Reply. N Engl J Med (2020) 0.75